An investigation for investors in NASDAQ:VIVO shares over potential securities laws violations by Meridian Bioscience, Inc. was announced and NASDAQ:VIVO stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/31/2017 -- An investigation was announced for investors of Meridian Bioscience, Inc. over potential securities laws violations in connection certain financial statements.
Investors who purchased shares of Meridian Bioscience, Inc. (NASDAQ:VIVO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Meridian Bioscience, Inc. (NASDAQ:VIVO) concerning whether a series of statements by Meridian Bioscience, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On January 25, 2017, Meridian Bioscience, Inc announced negative first-quarter 2017 fiscal year financial results, revised its previously issued revenue guidance for the 2017 fiscal year downwards, and announced that the Board of Directors reduced the annual indicated dividend rate.
Shares of Meridian Bioscience, Inc. (NASDAQ:VIVO) declined on January 25, 2017 to $10.75 per share.
On January 30, 2017, NASDAQ:VIVO shares closed at $12.95 per share.
Those who purchased shares of Meridian Bioscience, Inc. have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com